Abstract
Chemists have long recognized the value of online databases for surveying the literature of their field. Chemical Abstracts Service (CAS) databases covering almost a centurys worth of journal articles and patent documents are among the best known and widely used for searching information on compounds. Todays research presents a new challenge, however, as the boundaries of chemistry and biological sciences overlap increasingly. This trend is especially true in the drug discovery field where published findings relating to both chemical and biological entities and their interactions are examined. CAS has expanded its resources to meet the requirements of the new, interdisciplinary challenges faced by todays researchers. This is evident both in the content of CAS databases, which have been expanded to include more biology-related information, and in the technology of the search tools now available to researchers on their desktop. It is the integration of content and search-and-retrieval technology that enables new insights to be made in the vast body of accumulated information. CASs SciFinder® is a widely used research tool for this purpose.
Keywords: acs, biology, cas, chemistry, drug discovery, medicine, patents, pharmacology, protein
Current Drug Discovery Technologies
Title: Exploration Tools for Drug Discovery and Beyond: Applying SciFinder® to Interdisciplinary Research
Volume: 2 Issue: 2
Author(s): Margaret Haldeman, Barbara Vieira, Fred Winer and Lars J. S. Knutsen
Affiliation:
Keywords: acs, biology, cas, chemistry, drug discovery, medicine, patents, pharmacology, protein
Abstract: Chemists have long recognized the value of online databases for surveying the literature of their field. Chemical Abstracts Service (CAS) databases covering almost a centurys worth of journal articles and patent documents are among the best known and widely used for searching information on compounds. Todays research presents a new challenge, however, as the boundaries of chemistry and biological sciences overlap increasingly. This trend is especially true in the drug discovery field where published findings relating to both chemical and biological entities and their interactions are examined. CAS has expanded its resources to meet the requirements of the new, interdisciplinary challenges faced by todays researchers. This is evident both in the content of CAS databases, which have been expanded to include more biology-related information, and in the technology of the search tools now available to researchers on their desktop. It is the integration of content and search-and-retrieval technology that enables new insights to be made in the vast body of accumulated information. CASs SciFinder® is a widely used research tool for this purpose.
Export Options
About this article
Cite this article as:
Haldeman Margaret, Vieira Barbara, Winer Fred and Knutsen J. S. Lars, Exploration Tools for Drug Discovery and Beyond: Applying SciFinder® to Interdisciplinary Research, Current Drug Discovery Technologies 2005; 2 (2) . https://dx.doi.org/10.2174/1570163054064693
DOI https://dx.doi.org/10.2174/1570163054064693 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overexpression of a Modified Amaranth Protein in Escherichia coli with Minimal Media and Lactose as Inducer
Recent Patents on Biotechnology ACKNOWLEDGEMENTS TO REVIEWERS
Current Hypertension Reviews Editorial [Hot Topic: Complications in Pregnancy - Recent Developments in Preventive Strategies and Treatment Modalities (Executive Editor: A.C. Bolte)]
Current Pharmaceutical Design Renal Nerve Ablation for Hypertensive Patients with Chronic Kidney Disease
Current Vascular Pharmacology The Pleiotropic Effects of ARB in Vascular Endothelial Progenitor Cells
Current Vascular Pharmacology Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Immune System Alterations by Aldosterone During Hypertension: From Clinical Observations to Genomic and Non-Genomic Mechanisms Leading to Vascular Damage
Current Molecular Medicine Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics The Essential Role of Primary Caregiver in Early Detection of Familial Hypercholesterolemia and Cardiovascular Prevention
Current Pediatric Reviews Neurotoxicity of Ecstasy (MDMA): An Overview
Current Pharmaceutical Biotechnology Use of Paediatric Xylometazoline Nasal Drop is not a Child’s Play in Hypertensive Patients on Bisoprolol: A Case Report
Current Drug Safety Beta-Blocking Agents and Electroconvulsive Therapy
Current Drug Therapy L-Arginine Transport and Nitric Oxide Production in Kinin Receptor B1-/- Endothelial Cells.
Protein & Peptide Letters Biochemical and Molecular Basis of Insulin Resistance
Current Protein & Peptide Science Vitamin D Deficiency and Acute Lung Injury
Inflammation & Allergy - Drug Targets (Discontinued) Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy
Current Drug Targets Modifying Anti-Inflammatory Effect of Diclofenac with Murraya koenigii
Recent Patents on Inflammation & Allergy Drug Discovery PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)
Current Vascular Pharmacology Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis
Current Pharmaceutical Biotechnology